Pharma Intelligence Apps
18 Nov 2021
This campaign is based around a survey we are running with our subscribers around what the pharma industry wants from a CRO. They survey is being created at the moment and will be run via Steffan Herbage
Topic Market Intelligence
18 Nov 2021
Scrip's team of trusted industry experts bring you the mos critical news and analysis on key commercial topics, from licensing to clinical trials, and competitor activity, around the clock. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.
Pharma Intelligence Apps
18 Nov 2021
Get unrivalled coverage, news, and analysis of the global generics, biosimilars, and value-added medicines industries from the industry experts at Generics Bulletin. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.
Pharma Intelligence Apps
18 Nov 2021
Pharma Insights team of trusted journalists bring you the most critical news and analysis round the clock. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
18 Nov 2021
As we continue to navigate unprecedented times, the pharma industry in the Asia Pacific region has been persistently moving forward with clinical trial advancements.
Topic business-strategies
Citeline Engage: Supporting clinical trial planning and exec...
08 Nov 2021
Accelerate study startup, drive engagement, and enable community and communication surrounding your clinical trials with Citeline Connect, the only end-to-end platform supporting all aspects of clinical trial recruitment.
Citeline, Trialtrove: 医療用医薬品の臨床試験情報データベース
03 Nov 2021
Our annual analysis dissects the data of all Phase I–III clinical trials that started in a year dominated by COVID-19.
Topic Coronavirus
世界の薬事規制動向＆情報を配信
03 Nov 2021
Whether a child receives the 10 mcg dose of COVID-19 vaccine authorized for 5-11 year-olds or the 30 mcg dose authorized for ≥12 year-olds should be based on age on day of vaccination, CDC says, but FDA is allowing some dosing flexibility for kids who celebrate their 12th birthday in the middle of the primary series.
Generics Bulletin: ジェネリック＆バイオシミラーニュース
02 Nov 2021
Following a recent settlement in Louisiana, Teva has been told by a court in California it is not liable for the state’s opioid crisis, avoiding for now the potential for significant damages.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
By Alaric DeArment 02 Nov 2021
The company increased its guidance for sales of the COVID-19 vaccine again, to $36bn, though many other products’ sales were close to or below analyst expectations.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
02 Nov 2021
The US FDA has extended the user fee date by three months for the partners’ BCMA-targeting CAR-T therapy but its first-to-market rival is facing manufacturing challenges that limit access to treatment.
Medtech Insight: 世界の医療機器・医療技術の最新情報
02 Nov 2021
The medtech sector’s drive to create a fairer health care system and a greener world will go on after the COVID pandemic, which has brought such issues into sharp relief. CEOs at leading companies discuss environmental, social and governance imperatives for their companies and the larger industry.
Medtech Insight: 世界の医療機器・医療技術の最新情報
02 Nov 2021
The once and likely future FDA commissioner emphasized the value of randomized controlled trials, the fact that not all trials are good for people, and how decentralization and digitization are leaving people behind during a panel discussion.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
01 Nov 2021
In this week's podcast edition of Five Must-Know Things: Lilly goes head-to-head in Alzheimer’s; Roche eyes new opportunities for Lucentis; Novartis doubles down on innovation; BMS seeks growth amid generic threats; and the new head of Boehringer Ingelheim India talks to Scrip.
HBW Insight : コンシューマーヘルスケア産業のニュース
31 Oct 2021
While working to improve the quality of VMS products available in the US and to provide information on the products to consumers, the ODS doesn’t have authority to impose change on the industry or in the marketplace.
Scrip: 世界の医療用医薬品＆製薬産...
26 Nov 2021
Scrip: 世界の医療用医薬品＆製薬産...
26 Nov 2021
Scrip: 世界の医療用医薬品＆製薬産...
26 Nov 2021
Medtech Insight: 世界の...
26 Nov 2021
Scrip: 世界の医療用医薬品＆製薬産...
26 Nov 2021
HBW Insight : コンシューマ...
26 Nov 2021
Generics Bulletin: ジ...
26 Nov 2021
世界の薬事規制動向＆情報を配信
26 Nov 2021
Scrip: 世界の医療用医薬品＆製薬産...
26 Nov 2021
Scrip: 世界の医療用医薬品＆製薬産...
26 Nov 2021
HBW Insight : コンシューマ...
25 Nov 2021
Scrip: 世界の医療用医薬品＆製薬産...
25 Nov 2021
世界の薬事規制動向＆情報を配信
25 Nov 2021
Scrip: 世界の医療用医薬品＆製薬産...
25 Nov 2021
Medtech Insight: 世界の...
25 Nov 2021
Trialtrove(トライアルトローブ)は医療用医薬品の開発状況を常に把握できる医薬品業界随一の臨床試験情報データベースです。計画段階から完了まで、260疾患・29万件の臨床試験をトラッキングし、250以上の学会をカバーしています。4万以上の情報ソースから収録した臨床試験に関するデータを250名のアナリストが精査し、リアルタイムで更新しています。学会発表や企業発のニュースは即日収録されます。アラート機能や可視化ツールを活用することで、特定の臨床試験のモニタリングや資料作成も可能です。
Key benefits:
Datamonitor Healthcare(データモニターヘルスケア)では主要な疾患と医薬品をカバーする市場調査レポートを収載し、定期的に更新しています。市場調査レポート1本単位の購入または疾患単位の購読契約による対象の市場調査レポートすべての閲覧が可能です。新医薬品の市場性の評価や研究開発戦略の立案にご利用ください。
Key benefits:
Scrip（スクリプ）はアメリカとヨーロッパの医療用医薬品産業に関するニュース配信を強みとしながら、日本・中国・インドなどを中心とするアジア市場とその他新興国市場に関する医薬品ニュースも幅広くカバーしています。世界中に拠点を置くジャーナリストとアナリストによるニュース記事は、長年の経験と医薬品産業に関する深い知識に裏打ちされたものとして、世界中で多くの方にお読みいただいています。まずはお気軽に無料トライアルをお試しください。
Key benefits:
製品説明＆デモお申込
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
＊一部のサービスでは無料トライアルをご利用になれません。
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
お問い合わせ先
新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問い合わせの際は下記のフォームまたはメールアドレスをご利用下さい。
Eメール：inquiry.jp@informa.com
レポートストア
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。
